| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.03 |